We love our technology, and we are thankful for the scientific research which makes it all possible. But who funded all of that research? Dr. Moira Gunn speaks with Greg Lucier, CEO of Invitrogen, about his company and this nagging question.

On the Bio-Issue of the Week, David Ewing Duncan talks about the move to regulate nanotechnology in the United States.